PMC:7781431 / 17348-17663 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"496","span":{"begin":280,"end":285},"obj":"Gene"},{"id":"504","span":{"begin":41,"end":61},"obj":"Chemical"},{"id":"505","span":{"begin":63,"end":68},"obj":"Chemical"},{"id":"506","span":{"begin":71,"end":81},"obj":"Chemical"},{"id":"507","span":{"begin":119,"end":129},"obj":"Chemical"},{"id":"508","span":{"begin":157,"end":177},"obj":"Chemical"},{"id":"509","span":{"begin":179,"end":186},"obj":"Chemical"}],"attributes":[{"id":"A496","pred":"tao:has_database_id","subj":"496","obj":"Gene:2841"},{"id":"A504","pred":"tao:has_database_id","subj":"504","obj":"MESH:C465623"},{"id":"A505","pred":"tao:has_database_id","subj":"505","obj":"MESH:C465623"},{"id":"A506","pred":"tao:has_database_id","subj":"506","obj":"MESH:C078814"},{"id":"A507","pred":"tao:has_database_id","subj":"507","obj":"MESH:C078814"},{"id":"A508","pred":"tao:has_database_id","subj":"508","obj":"MESH:C479832"},{"id":"A509","pred":"tao:has_database_id","subj":"509","obj":"MESH:C479832"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"These include endogenous ligands such as N-arachidonylglycine (NAGly), anandamide, a metabolite of the endocannabinoid anandamide, synthetic ligands such as abnormal-cannabidiol (Abn-CBD), and O-1918, a partial agonist, which can be used as a pharmacological tool to inhibit DRV2/GPR18 signalling (Offertaler et al."}

{"project":"LitCovid-sentences","denotations":[{"id":"T173","span":{"begin":0,"end":315},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"These include endogenous ligands such as N-arachidonylglycine (NAGly), anandamide, a metabolite of the endocannabinoid anandamide, synthetic ligands such as abnormal-cannabidiol (Abn-CBD), and O-1918, a partial agonist, which can be used as a pharmacological tool to inhibit DRV2/GPR18 signalling (Offertaler et al."}